These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 23490430)
1. Selective serotonin reuptake inhibitors reduce P2Y12 receptor-mediated amplification of platelet aggregation. Tseng YL; Chiang ML; Lane HY; Su KP; Lai YC Thromb Res; 2013 Apr; 131(4):325-32. PubMed ID: 23490430 [TBL] [Abstract][Full Text] [Related]
2. Micromolar concentrations of citalopram or escitalopram inhibit glycoprotein VI-mediated and integrin αIIbβ3-mediated signaling in human platelets. Tseng YL; Braun A; Chang JP; Chiang ML; Tseng CY; Chen W Toxicol Appl Pharmacol; 2019 Feb; 364():106-113. PubMed ID: 30592962 [TBL] [Abstract][Full Text] [Related]
3. Inhibitory Effect of Flavonolignans on the P2Y12 Pathway in Blood Platelets. Bijak M; Szelenberger R; Dziedzic A; Saluk-Bijak J Molecules; 2018 Feb; 23(2):. PubMed ID: 29439388 [TBL] [Abstract][Full Text] [Related]
4. Adenosine diphosphate (ADP)-induced thromboxane A(2) generation in human platelets requires coordinated signaling through integrin alpha(IIb)beta(3) and ADP receptors. Jin J; Quinton TM; Zhang J; Rittenhouse SE; Kunapuli SP Blood; 2002 Jan; 99(1):193-8. PubMed ID: 11756171 [TBL] [Abstract][Full Text] [Related]
5. A selective serotonin reuptake inhibitor, citalopram, inhibits collagen-induced platelet aggregation and activation. Tseng YL; Chiang ML; Huang TF; Su KP; Lane HY; Lai YC Thromb Res; 2010 Dec; 126(6):517-23. PubMed ID: 20961601 [TBL] [Abstract][Full Text] [Related]
6. Prostaglandin E1 potentiates the effects of P2Y12 blockade on ADP-mediated platelet aggregation in vitro: Insights using short thromboelastography. Khanna V; Armstrong PC; Warner TD; Curzen N Platelets; 2015; 26(7):689-92. PubMed ID: 25734957 [TBL] [Abstract][Full Text] [Related]
7. P2Y12 antagonist ticagrelor inhibits the release of procoagulant extracellular vesicles from activated platelets. Gasecka A; Nieuwland R; van der Pol E; Hajji N; Ćwiek A; Pluta K; Konwerski M; Filipiak KJ Cardiol J; 2019; 26(6):782-789. PubMed ID: 29671861 [TBL] [Abstract][Full Text] [Related]
8. Synergistic Inhibition of Both P2Y1 and P2Y12 Adenosine Diphosphate Receptors As Novel Approach to Rapidly Attenuate Platelet-Mediated Thrombosis. Gremmel T; Yanachkov IB; Yanachkova MI; Wright GE; Wider J; Undyala VV; Michelson AD; Frelinger AL; Przyklenk K Arterioscler Thromb Vasc Biol; 2016 Mar; 36(3):501-9. PubMed ID: 26743169 [TBL] [Abstract][Full Text] [Related]
9. ADP-stimulated activation of Akt during integrin outside-in signaling promotes platelet spreading by inhibiting glycogen synthase kinase-3β. O'Brien KA; Gartner TK; Hay N; Du X Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2232-40. PubMed ID: 22814751 [TBL] [Abstract][Full Text] [Related]
10. Comparison of a new P2Y12 receptor specific platelet aggregation test with other laboratory methods in stroke patients on clopidogrel monotherapy. Bagoly Z; Sarkady F; Magyar T; Kappelmayer J; Pongrácz E; Csiba L; Muszbek L PLoS One; 2013; 8(7):e69417. PubMed ID: 23844259 [TBL] [Abstract][Full Text] [Related]
11. 1, 6-di-O-caffeoyl-β-D-glucopyranoside, a natural compound from Callicarpa nudiflora Hook impairs P2Y Fu J; Zhu X; Wang W; Lu H; Zhang Z; Liu T; Xu H; Fu H; Ma S; Luo Y Phytomedicine; 2017 Dec; 36():273-282. PubMed ID: 29157825 [TBL] [Abstract][Full Text] [Related]
13. The P2Y(12) antagonists, 2MeSAMP and cangrelor, inhibit platelet activation through P2Y(12)/G(i)-dependent mechanism. Xiang B; Zhang G; Ren H; Sunkara M; Morris AJ; Gartner TK; Smyth SS; Li Z PLoS One; 2012; 7(12):e51037. PubMed ID: 23236426 [TBL] [Abstract][Full Text] [Related]
14. Blockade of the purinergic P2Y12 receptor greatly increases the platelet inhibitory actions of nitric oxide. Kirkby NS; Lundberg MH; Chan MV; Vojnovic I; Solomon AB; Emerson M; Mitchell JA; Warner TD Proc Natl Acad Sci U S A; 2013 Sep; 110(39):15782-7. PubMed ID: 24003163 [TBL] [Abstract][Full Text] [Related]
15. Molecular basis for ADP-induced platelet activation. II. The P2Y1 receptor mediates ADP-induced intracellular calcium mobilization and shape change in platelets. Jin J; Daniel JL; Kunapuli SP J Biol Chem; 1998 Jan; 273(4):2030-4. PubMed ID: 9442040 [TBL] [Abstract][Full Text] [Related]
16. The role of adenosine diphosphate mediated platelet responsiveness for the stability of platelet integrity in citrated whole blood under ex vivo conditions. Koessler J; Schwarz M; Weber K; Etzel J; Koessler A; Boeck M; Kobsar A PLoS One; 2017; 12(11):e0188193. PubMed ID: 29155852 [TBL] [Abstract][Full Text] [Related]
17. Effect of clopidogrel administration to healthy volunteers on platelet phosphorylation events triggered by ADP. Contreres JO; Dupuy E; Job B; Habib A; Bryckaert M; Rosa JP; Simoneau G; Herbert JM; Savi P; Levy-Toledano S Br J Haematol; 2003 Feb; 120(4):633-42. PubMed ID: 12588350 [TBL] [Abstract][Full Text] [Related]
18. Potentiation of TRAP-6-induced platelet dense granule release by blockade of P2Y Mitrugno A; Rigg RA; Laschober NB; Ngo ATP; Pang J; Williams CD; Aslan JE; McCarty OJT Platelets; 2018 Jun; 29(4):383-394. PubMed ID: 28523947 [TBL] [Abstract][Full Text] [Related]
19. Adenosine derived from ADP can contribute to inhibition of platelet aggregation in the presence of a P2Y12 antagonist. Iyú D; Glenn JR; White AE; Fox SC; Heptinstall S Arterioscler Thromb Vasc Biol; 2011 Feb; 31(2):416-22. PubMed ID: 21106949 [TBL] [Abstract][Full Text] [Related]